课题基金 / 基金详情

Innate immune cells in the pathogenesis of PSC

Innate immune cells in the pathogenesis of PSC
PSC发病机制中的先天免疫细胞
批准号:
290523246
负责人:
Professor Dr. Marcus Altfeld
金额:
$0.0万
依托单位国家:
德国
项目类别:
Clinical Research Units
财政年份:
2016
资助国家:
德国
项目状态:
已结题
起止时间:
2015-12-31 至 2020-12-31

项目摘要

项目成果

Professor Dr. Marcus Altfeld的其他基金

相似基金

相关文献

中文摘要
翻译
背景/初步研究结果:PSC慢性免疫激活的原因尚不清楚,但胆汁毒性和微生物识别被认为是重要的触发因素。由于细胞死亡和微生物主要由先天免疫细胞感知,这些细胞可能在PSC中被激活,并可能代表致病免疫反应的关键驱动因素。事实上,利用PSC的小鼠模型,我们发现对胆管损伤的直接反应是门管区树突状细胞的扩张和激活,随后触发单核细胞衍生细胞和中性粒细胞向门管区的募集。值得注意的是,树突状细胞和单核细胞来源的细胞似乎在炎症的门脉区域组织随后的先天和获得性免疫反应。我们进一步观察到,在PSC患者中,NK细胞也被激活和扩张,并表达趋化因子受体,提示NK细胞迁移到炎症的肝脏,在那里它们参与了门静脉慢性进行性炎症。假设:感知胆管细胞死亡的先天免疫细胞和微生物特性是PSC的主要致病因素。先天免疫细胞群体采用一种既维持慢性胆管损伤又维持重建的表型。工作计划:1.我们将通过转录图谱、多色流式细胞术和细胞耗竭研究来分析树突状细胞和单核细胞衍生细胞群体在小鼠胆管炎中的功能相关性。2.通过多色流式细胞术和细胞耗竭实验,分析小鼠胆管炎中树突状细胞和单核细胞来源的细胞群对T细胞应答的影响。3.我们将通过转录图谱和多色流式细胞术鉴定PSC患者肝脏中的抗原提呈细胞群,以及它们导致NK细胞募集的趋化因子分泌模式。4.通过共培养和多色流式细胞术研究人类PSC中HLAII类细胞在NK细胞与APC相互作用中的作用。
英文摘要
Background / Preliminary findings: The causes of chronic immune activation in PSC are not known, but bile toxicity and microbial recognition are believed to be important triggers. As cell death and microbes are primarily sensed by innate immune cells, these cells might be activated in PSC and might represent critical drivers of the pathogenic immune response. Indeed, using mouse models of PSC, we found that the immediate response to biliary injury is the expansion and activation of dendritic cells in the portal field, which subsequently triggers the recruitment of monocyte-derived cells and neutrophils to the portal tract. Notably dendritic cells and monocyte-derived cells seem to organise the subsequent innate and adaptive immune response in the inflamed portal field. We furthermore observed that NK cells are also activated and expanded in patients with PSC, and express chemokine receptors, suggesting migration of NK cells into the inflamed liver where they contribute to the chronic progressive inflammation of portal tracts.Hypothesis: Innate immune cells sensing biliary cell death and microbial traits are essential pathogenic drivers in PSC. Innate immune cell populations adopt a phenotype that sustains both chronic biliary injury and remodelling.Work programme: 1. We will analyse the functional relevance of dendritic cell and monocyte-derived cell populations in murine cholangitis by transcriptional profiling, multi-colour flow cytometry, and cell depletion studies. 2. We will analyse the effect of dendritic cell and monocyte-derived cell populations in murine cholangitis on T cell responses by multi-colour flow cytometry, and cell depletion studies. 3. We will characterize antigen-presenting cell populations in the liver of PSC patients, and their chemokine secretion patterns resulting in NK cell recruitment by transcriptional profiling, and multi-colour flow cytometry. 4. We will study the role of HLA class II in the interaction between NK cells and APCs in human PSC by co-culture studies and multi-colour flow cytometry.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Consequences of CTL-mediated immune pressure for HIV-1 capsid stability and innate sensing
  • 批准号:
    318290718
  • 项目类别:
    Priority Programmes
  • 资助金额:
    $0.0万
  • 财政年份:
    2016
  • 负责人:
    Professor Dr. Marcus Altfeld
  • 依托单位:
Hormonal modulation of the Type I Interferon response during pregnancy: implications formaternal health and disease
  • 批准号:
    269121614
  • 项目类别:
    Clinical Research Units
  • 资助金额:
    $0.0万
  • 财政年份:
    2015
  • 负责人:
    Professor Dr. Marcus Altfeld
  • 依托单位:
Impact of calcium and adenine nucleotide signaling on education and functionality of NK cells
  • 批准号:
    516286863
  • 项目类别:
    Research Grants
  • 资助金额:
    $0.0万
  • 财政年份:
    --
  • 负责人:
    Professor Dr. Marcus Altfeld
  • 依托单位:
Regulation of immune cell populations and immune pathways by sex hormones
国内基金
海外基金
声致离子电流促进小胶质细胞M2极化阻断再生神经瘢痕退变免疫机制
  • 批准号:
    82371973
  • 项目类别:
    面上项目
  • 资助金额:
    48.00万元
  • 批准年份:
    2023
  • 负责人:
    孙迪
  • 依托单位:
转运蛋白RCP调控巨噬细胞脂肪酸氧化参与系统性红斑狼疮发病的机制研究
  • 批准号:
    82371798
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    叶俊娜
  • 依托单位:
基于FCER1G基因介导免疫反应探讨迟发性聋与认知障碍相关性的机制研究
  • 批准号:
    82371141
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    陈颖
  • 依托单位:
CD27-CD28-CD8+T细胞调控儿童肝脏移植免疫耐受形成的作用和机制
  • 批准号:
    82371791
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    刘永波
  • 依托单位: